[HTML][HTML] Tocilizumab in patients hospitalized with Covid-19 pneumonia
C Salama, J Han, L Yau, WG Reiss… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated
with hyperinflammation. Despite the disproportionate incidence of Covid-19 among …
with hyperinflammation. Despite the disproportionate incidence of Covid-19 among …
[HTML][HTML] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, WG Reiss… - New England …, 2021 - journalwise.acponline.org
Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
[PDF][PDF] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, GJ Criner, E Kaplan-Lewis… - 2020 - pilotforpulmonary.org
BACKGROUND Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, WG Reiss, B Kramer… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
[HTML][HTML] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, WG Reiss… - New England Journal …, 2021 - covid19.sld.cu
Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, WG Reiss… - … England Journal of …, 2021 - ecommons.aku.edu
Background: Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, WG Reiss, B Kramer… - New England Journal …, 2021 - cir.nii.ac.jp
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[PDF][PDF] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, GJ Criner, E Kaplan-Lewis… - 2020 - researchgate.net
BACKGROUND Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
Tocilizumab in patients hospitalized with Covid-19 pneumonia
C Salama, J Han, L Yau, WG Reiss… - New England Journal …, 2021 - scholars.aku.edu
BACKGROUND Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
[PDF][PDF] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
C Salama, J Han, L Yau, GJ Criner… - N Engl J …, 2021 - centroestudosemilioribas.org.br
BACKGROUND Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved …